Keyphrases
Methylphenidate
100%
Hepatitis C Virus
77%
Na +
65%
People Who Inject Drugs
58%
Attention Deficit Hyperactivity Disorder
58%
Hepatitis C
51%
Scotland
44%
Hepatitis C Treatment
44%
Randomized Controlled Trial
35%
Airway Epithelial Cells
34%
Chronic Effects
34%
Drug Use
34%
Cluster Randomized Trial
34%
Pharmacy
34%
Conductance
33%
Community Pharmacy
32%
Opioid Substitution Treatment
27%
Methylphenidate Treatment
26%
Tayside
23%
H441
23%
Direct Observed Therapy
23%
Effect Study
23%
Treatment Regimen
23%
Serum and Glucocorticoid-regulated Kinase 1
23%
Clinical Efficacy
23%
Antiviral Treatment
23%
Injecting Equipment
23%
Young children
23%
HCV Treatment
23%
Care Pathway
21%
Prison
20%
HCO3
19%
Na+ Transport
18%
SVR12
17%
Point-of-care
17%
Bronchi
17%
Clinical Trials
17%
Forskolin
17%
Epithelial Sodium Channel (ENaC)
16%
Sustained Virological Response
16%
Hepatitis C Virus RNA
16%
Syrinx
16%
ADHD Medication
15%
Na+ Absorption
15%
Adverse Events
15%
Lung
15%
Conventional Care
15%
Stimulant Medication
15%
Direct-acting Antivirals
14%
Wheezing
14%
Medicine and Dentistry
Hepatitis C Virus
46%
Methylphenidate
34%
Attention Deficit Disorder
34%
Adolescence
34%
Drug Use
23%
Sodium Ion
23%
Cohort Analysis
23%
Toddlers
23%
Hepatitis C
23%
Care Pathway
16%
Wheeze
15%
Drug Therapy
15%
Respiratory Tract Infection
14%
Messenger RNA
13%
Base
11%
Meta-Analysis
11%
Mannose Binding Lectin
11%
Respiratory Disease
11%
Secretion (Process)
11%
COVID-19
11%
Community-Acquired Pneumonia
11%
Potassium Ion
11%
Barium Ion
11%
Epithelial Sodium Channel
11%
Systematic Review
11%
Bupivacaine
11%
Observational Study
11%
Hepacivirus
11%
Adverse Drug Reaction
11%
Antiviral Therapy
11%
Placebo
11%
Virus RNA
11%
Epithelial Cell
11%
Diagnosis
11%
Odds Ratio
11%
Reinfection
9%
Bronchiolitis
8%
5 (N,n Dimethyl)amiloride
8%
Community Pharmacy
7%
Lung
6%
Transcription Factor Nrf2
5%
Sulforaphane
5%
Bumetanide
5%
Hospital Care
5%
National Health Service
5%
Nurse
5%
Infection
5%
